Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Atara Biotherapeutics Inc shares valued at $17,888 were sold by Touchon Pascal on Mar 04 ’24. At $0.72 per share, Touchon Pascal sold 24,844 shares. The insider’s holdings dropped to 1,910,652 shares worth approximately $1.38 million following the completion of this transaction.
Also, Nguyen AnhCo sold 10,746 shares, netting a total of over 7,737 in proceeds. Following the sale of shares at $0.72 each, the insider now holds 941,397 shares.
Before that, Murugan Amar had sold 10,044 shares from its account. In a trade valued at $7,232, the EVP, Chief Legal Officer traded Atara Biotherapeutics Inc shares for $0.72 each. Upon closing the transaction, the insider’s holdings decreased to 10,044 shares, worth approximately $0.52 million.
As published in a research note from Mizuho on November 09, 2023, Atara Biotherapeutics Inc [ATRA] has been rated down from a Buy to a Neutral and the price target has been revised to $1 from $31. Analysts at H.C. Wainwright downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early November. As of November 09, 2023, Evercore ISI has decreased its “an Outperform” rating to a “an In-line” for ATRA. Earlier on July 20, 2022, Citigroup downgraded its rating. Their new recommendation was “a Sell” for ATRA stock which previously was a “a Neutral”.
Analyzing ATRA Stock Performance
During the last five days, there has been a drop of approximately -0.32%. Over the course of the year, Atara Biotherapeutics Inc shares have jumped approximately 39.96%. Shares of the company reached a 52-week high of $1.5800 on 02/02/24 and a 52-week low of $0.4323 on 01/03/24. A 50-day SMA is recorded $0.7607, while a 200-day SMA reached $1.1427. Nevertheless, trading volume fell to 0.65 million shares from 1.54 million shares the previous day.
Support And Resistance Levels for Atara Biotherapeutics Inc (ATRA)
According to the 24-hour chart, there is a support level at 0.6880, which, if violated, would cause prices to drop to 0.6584. In the upper region, resistance lies at 0.7493. The next price resistance is at 0.7810. RSI (Relative Strength Index) is 49.45 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0239, which suggests the price will decrease in the coming days. Percent R is at 53.87%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Atara Biotherapeutics Inc subject to short interest?
Stocks of Atara Biotherapeutics Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 0.16 million shares to 11.03 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 10.87 million shares. A jump of 1.45% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.32 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.32.
